Dr. Jonathan M Edelman M.D.
Pulmonologist | Pulmonary Disease
232 Winding Way Merion Station PA, 19066About
Dr. Jonathan Edelman practices Pulmonology in Merion Station, PA. A pulmonologist is a physician who possesses specialized knowledge and skill in the diagnosis and treatment of pulmonary conditions and diseases. Dr. Edelman manages patients who need life support and mechanical ventilation, and is specially trained in diseases and conditions of the chest, particularly pneumonia, asthma, tuberculosis, emphysema, and complicated chest infections.
Education and Training
Icahn School of Medicine at Mount Sinai 1983
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
- Effects of montelukast and beclomethasone on airway function and asthma control.
- Asthma control and patient satisfaction among early pediatric users of montelukast.
- Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
- Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.
- Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study.
- Evaluation of parental preference for the treatment of asthmatic children aged 6 to 11 years with oral montelukast or inhaled cromolyn: a randomized, open-label, crossover study.
- Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
- Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
- Pharmacokinetics of indinavir and ritonavir administered at 667 and 100 milligrams, respectively, every 12 hours compared with indinavir administered at 800 milligrams every 8 hours in human immunodeficiency virus-infected patients.
- A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge.
- Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
- Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.
- Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
- The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.
Dr. Jonathan M Edelman M.D.'s Practice location
Dr. Jonathan M Edelman M.D.'s reviews
Write ReviewRecommended Articles
- Pulse Oximeter Use for Patients with COPD
Pulse oximeters measure the pulse rate of an individual, which is usually marked by a small heart. This is the first number that appears while using a pulse oximeter. It also measures the proportion of oxygenated hemoglobin in the blood within pulsating vessels. This determines the level of oxygen...
- Study Concludes At-home Antibiotic Therapy for Cystic Fibrosis No Riskier than at Hospital
Many patients would generally perform to have their treatments done at home than in a hospital; it's a familiar place, the patient can be more comfortable, travel isn’t necessary. It was assumed, however, that intravenous antibiotic treatment for cystic fibrosis patients would not be as safe at...
- Helping a Child with Cystic Fibrosis Find Hope
Cystic fibrosis is a serious and debilitating illness that is lifelong, affecting people often from infancy. What some people may not realize is how difficult it may be for children to understand what is happening to their body.Most small children with the disease have gone through more difficult...
- Make-A-Wish Foundation Gives Teen with Cystic Fibrosis a Dream Come True
The Make-A-Wish Foundation is well known among those suffering from chronic illness and the population at large. The foundation has made many headlines for keeping true to its mission to “grant the wish of every child diagnosed with a life-threatening medical condition.” And that’s exactly...
- What a Lung Transplantation for Cystic Fibrosis Is Really Like
Cystic fibrosis has been one of the more devastating and debilitating diseases to take hold of the population. The condition has forced countless research studies, clinical trials, and innovative treatments to try and mitigate the symptoms and effects of cystic fibrosis. One of the riskier but...
- What is Cystic Fibrosis?
Cystic fibrosis is a life-threatening, inherited disorder, which affects the secretory glands producing mucus and sweat. Fluids secreted by the glands are usually thin. In this disease, the secretions become thick and sticky and block all passageways and ducts, particularly of the lungs and...